Serine- and Arginine-rich Proteins 55 and 75 (SRp55 and SRp75) Induce Production of HIV-1 vpr mRNA by Inhibiting the 5′-Splice Site of Exon 3

被引:21
作者
Tranell, Anna [1 ]
Fenyo, Eva Maria [2 ]
Schwartz, Stefan [1 ,3 ]
机构
[1] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, BMC, S-75123 Uppsala, Sweden
[2] Lund Univ, Dept Lab Med, S-22362 Lund, Sweden
[3] Dublin Inst Technol, Dublin 8, Ireland
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS TYPE-16; SPLICING FACTOR SF2/ASF; GENE-EXPRESSION; TAT EXON-2; HNRNP A1; UNTRANSLATED REGION; FUNCTIONAL-ANALYSIS; SILENCER ELEMENT/; EPITHELIAL-CELLS;
D O I
10.1074/jbc.M109.077453
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV-1 non-coding exon 3 can either be spliced to exons 4, 4a, 4b, 4c, and 5 to generate tat, rev, and nef mRNAs or remain unspliced to produce the 13a7 vpr mRNA. Here we show that serine-and arginine-rich proteins 55 and 75 (SRp55 and SRp75) inhibit splicing from the 5'-splice site of exon 3 thereby causing an accumulation of the partially unspliced 13a7 vpr mRNA. In contrast, serine- and arginine-rich protein 40 (SRp40) induces splicing from exon 3 to exon 4, thereby promoting the production of the 1347 tat mRNA. We demonstrate that SRp55 stimulates vpr mRNA production by interacting with the previously identified HIV-1 splicing enhancer named GAR and inhibiting its function. This inhibition requires both serine arginine-rich and RNA-binding domains of SRp55, indicating that production of HIV-1 vpr mRNA depends on the interaction of SRp55 with an unknown factor.
引用
收藏
页码:31537 / 31547
页数:11
相关论文
共 48 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]  
AMENDT BA, 1995, MOL CELL BIOL, V15, P6480
[3]   PRESENCE OF NEGATIVE AND POSITIVE CIS-ACTING RNA SPLICING ELEMENTS WITHIN AND FLANKING THE FIRST TAT CODING EXON OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
AMENDT, BA ;
HESSLEIN, D ;
CHANG, LJ ;
STOLTZFUS, CM .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) :3960-3970
[4]   CHARACTERIZATION AND EXPRESSION OF NOVEL SINGLY SPLICED RNA SPECIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
ARRIGO, SJ ;
WEITSMAN, S ;
ZACK, JA ;
CHEN, ISY .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4585-4588
[6]   RNA splicing at human immunodeficiency virus type 1 3′ splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element [J].
Bilodeau, PS ;
Domsic, JK ;
Mayeda, A ;
Krainer, AR ;
Stoltzfus, CM .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8487-8497
[7]   REGULATION OF ALTERNATIVE SPLICING IN-VIVO BY OVEREXPRESSION OF ANTAGONISTIC SPLICING FACTORS [J].
CACERES, JF ;
STAMM, S ;
HELFMAN, DM ;
KRAINER, AR .
SCIENCE, 1994, 265 (5179) :1706-1709
[8]   FUNCTIONAL-ANALYSIS OF PREMESSENGER RNA SPLICING FACTOR SF2/ASF STRUCTURAL DOMAINS [J].
CACERES, JF ;
KRAINER, AR .
EMBO JOURNAL, 1993, 12 (12) :4715-4726
[9]   A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression [J].
Caputi, M ;
Freund, M ;
Kammler, S ;
Asang, C ;
Schaal, H .
JOURNAL OF VIROLOGY, 2004, 78 (12) :6517-6526
[10]   ESEfinder: a web resource to identify exonic splicing enhancers [J].
Cartegni, L ;
Wang, JH ;
Zhu, ZW ;
Zhang, MQ ;
Krainer, AR .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3568-3571